Author: Mark Newman
Is It Time for a New Approach to Treating Cushing’s Syndrome?
Endocrine Society Advocates for Increased Immunization Rates
With flu season in full swing, the Endocrine Society encourages its members to help “Raise the Rates” and increase adult immunization rates among their patients. Raise the Rates is an initiative led by the American College of Physicians (ACP) to help internists and other primary care providers in both understanding the immunization rates of their...
EU Chemicals Strategy Advances Endocrine Society EDC Priorities
As the European Commission makes progress towards implementation of the Chemicals Strategy for Sustainability (CSS), the Endocrine Society continues to provide input to ensure that the strategy modernizes the European Union’s approach to identification and regulation of endocrine-disrupting chemicals (EDCs). Our members are providing feedback in several different ways, including as a member of the...
New Stem Cell-Derived Treatment for Type 1 Diabetes Shows Promising Results in New Studies
Positive preliminary results of an ongoing, first-in-human Phase 1/2 study demonstrating that stem cell-derived therapy can produce insulin in people with severe type 1 diabetes were published today in Cell Stem Cell and Cell Reports Medicine. “The data from these papers represent a significant scientific advance,” said Cell Reports Medicine study lead author James Shapiro, MD PhD, Canada...
Medicare Releases Physician Fee Schedule Final Rule for 2022
The Center for Medicare and Medicaid Services (CMS) released its final rule for the Medicare Physician Fee Schedule (MPFS) for calendar year 2022. Earlier this year, the Endocrine Society provided detailed comments on the proposed rule. While we still have serious concerns, several of our recommendations to benefit endocrinologists were incorporated into the final rule....
Transgender Women May Be More Prone to Type 2 Diabetes than Cisgender Women
The Endocrine Society advocates on behalf of our members, the patients they treat, and the science they research. Though our work in 2021 remained virtual, we successfully advocated for our policy priorities and raised the visibility of the value of endocrinology and endocrine research. Let’s look back at some of our wins from this year....